The Traditional Chinese Medicine Fumigation Machines market size is estimated at US$ 412 million in 2025, up from US$ 298 million in 2021, propelled by a 2021-2025 CAGR of 8.1%. Looking ahead, the market forecast points to a 9.3% CAGR (2026-2033) as hospital procurement budgets rebound, community TCM clinics expand, and export registrations surge in ASEAN and the Middle East. Macro drivers include China’s “Healthy China 2030” budget (¥8 trillion TCM segment), reimbursement list expansions, and post-pandemic wellness tourism. Technology shifts—notably IoT-enabled precise temperature-humidity control cartridges and AI-driven herbal-blend recommendation engines—are differentiating premium units from low-cost portables. Regulatory tightening (NMPA Class II device re-certification and CE MDR) is consolidating the field, while consumer behavior skews toward home-use tabletop models with silent operation and app-based session tracking. East Asia remains the largest region, commanding 68% of 2025 revenues, but Middle East & Africa is the fastest-growing region, scaling at >12% CAGR through hospital PPP projects and **tele-TCM roll-outs.